Shanghai Haixin Group Co Ltd
SSE:600851
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/S
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Valuation Scenarios
If P/S returns to its 3-Year Average (4.1), the stock would be worth ¥4.35 (48% downside from current price).
| Scenario | P/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 7.8 | ¥8.33 |
0%
|
| 3-Year Average | 4.1 | ¥4.35 |
-48%
|
| 5-Year Average | 4.3 | ¥4.61 |
-45%
|
| Industry Average | 3.9 | ¥4.2 |
-50%
|
| Country Average | 2.8 | ¥2.95 |
-65%
|
Forward P/S
Today’s price vs future revenue
Peer Comparison
| Market Cap | P/S | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
|
Shanghai Haixin Group Co Ltd
SSE:600851
|
6.1B CNY | 7.8 | 39.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883B USD | 14 | 44.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
553.5B USD | 5.7 | 26.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.2 | 20.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
209.6B GBP | 4.7 | 27.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
221.1B CHF | 5 | 20.7 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
270.2B USD | 4.3 | 15.2 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK | 4 | 12.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
151.8B USD | 2.4 | 19.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122B USD | 2.4 | 16.7 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.5 |
| Median | 2.8 |
| 70th Percentile | 5.4 |
| Max | 5 034 353.9 |
Other Multiples
Shanghai Haixin Group Co Ltd
Glance View
Shanghai Haixin Group Co., Ltd. engages in the production and sale of plush fabrics & clothing, and medical products. The company is headquartered in Shanghai, Shanghai and currently employs 1,021 full-time employees. The firm operates its business through two segments. The Textile segment is mainly engaged in the production and sales of plush fabric and clothing. The Pharmaceutical segment is mainly engaged in the manufacture and sales of pharmaceutical products. In addition, The Company is also engaged in financial investment business and industrial plant rental management business. The firm operates its business in the domestic market and overseas markets.
